Excited to share our latest work, UltraSEQ, a novel clinical metagenomics platform that is powered by biology and data science! #Bioinformatics#publication#Battelle
@bielleogy I developed some of these kind of hybrid amplicon protocols back in grad school. For example, you can target V1 as your R1 and V4 as your R2. Read’s won’t overlap, but you can separately analyze them. Otherwise, if you can afford it, long read would be better
Good, but still not enough. I quit my postdoc at NASA JPL after my 1st year contract ended because I found the $60k salary far below cost of living in Pasadena, Ca. Especially since we we’re starting a family. #postdoc#phdchat
@thekatestewart@AcademicChatter 1. Negotiated a higher salary (programs only set a minimum stipend, not max)
2. Lived in a cheap midwestern city
3. Side jobs (photography, online opps)
Privileges: no student loans, partner also had a similarly paying job
@dgkeyes Whenever I have worked with highly sensitive data, usually its at an institution that has its own enterprise GitHub that’s not open to public. Depending on the institutional data policy and security classification of data, private repos can be used.
Our recent work on classifying hazardous biological sequences using a function-based fingerprinting approach was just published. This approach can also be used to distinguish between closely related pathogenic & nonpathogenic bacteria. https://t.co/tqg1dn5U4p
@dbngsh_mkhrj Oh ya, publishing negative results should be encouraged. But negative result is result too, not expecting “any” result would be a bit worrisome :)
@devashismukerji Will take you to Bob Evans next time you are here, but please, Cici’s and Golden Coral be ready for getting sick after. Add White Castle to the list, maybe.